These data suggest that PP2A might be inhibited in lung tumours, because its biological inhibitor I2PP2A/SET is highly expressed, whereas PP2A activator C18-ceramide (Mukhopadhyay et al, 2009) is lower in these tumour tissues compared to controls. Here, PTPA is linked to neoplasm.